Atlas Trials

Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

Clinical trial NCT00926055 · WITHDRAWN

Trial details

NCT number
NCT00926055
Sponsor
Korea University
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Atherosclerosis
Start date
2011-09-01
Primary completion
2012-09-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.